{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:43:36Z","timestamp":1792806216329,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s40266-015-0293-6","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T08:36:17Z","timestamp":1441269377000},"page":"717-726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Pharmaceutical Management of Trigeminal Neuralgia in the Elderly"],"prefix":"10.1007","volume":"32","author":[{"given":"M. A. E.-M.","family":"Oomens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Forouzanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,4]]},"reference":[{"issue":"1","key":"293_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1129-2377-14-37","volume":"14","author":"JM Zakrzewska","year":"2013","unstructured":"Zakrzewska JM. Multi-dimensionality of chronic pain of the oral cavity and face. J Headache Pain. 2013;14(1):37.","journal-title":"J Headache Pain."},{"issue":"1","key":"293_CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00002508-200201000-00003","volume":"18","author":"JM Zakrzewska","year":"2002","unstructured":"Zakrzewska JM. Diagnosis and differential diagnosis of trigeminal neuralgia. Clin J Pain. 2002;18(1):14\u201321.","journal-title":"Clin J Pain"},{"issue":"9","key":"293_CR3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version. Cephalalgia. 2013;33(9):629\u2013808.","journal-title":"Cephalalgia."},{"issue":"11","key":"293_CR4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/TCRM.S37592","volume":"24","author":"N Montano","year":"2015","unstructured":"Montano N, Connforti G, Di Bonaventura R, Meglio M, Fernandez E, Papacci F. Advances in diagnosis and treatment of trigeminal neuralgia. Ther Clin Risk Manag. 2015;24(11):289\u201399.","journal-title":"Ther Clin Risk Manag."},{"issue":"348","key":"293_CR5","doi-asserted-by":"crossref","first-page":"g474","DOI":"10.1136\/bmj.g474","volume":"17","author":"JM Zakrzewska","year":"2014","unstructured":"Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ. 2014;17(348):g474.","journal-title":"BMJ."},{"key":"293_CR6","first-page":"CD005451","volume":"1","author":"PJ Wiffen","year":"2011","unstructured":"Wiffen PJ, Derry S, Moore RA, McQuay HJ. Carbamazepine for acute and chronic pain in adults. Cochrane Database Syst Rev. 2011;1:CD005451. doi: 10.1002\/14651858.CD005451.pub2 .","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"293_CR7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.22.1.36","volume":"22","author":"E Kugelberg","year":"1959","unstructured":"Kugelberg E, Lindblom U. The mechanism of the pain in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1959;22(1):36\u201343.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"5","key":"293_CR8","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/foc.2005.18.5.4","volume":"18","author":"JL Eller","year":"2005","unstructured":"Eller JL, Raslan AM, Burchiel KJ. Trigeminal neuralgia: definition and classification. Neurosurg Focus. 2005;18(5):E3.","journal-title":"Neurosurg Focus."},{"issue":"15","key":"293_CR9","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1212\/01.wnl.0000326598.83183.04","volume":"71","author":"G Gronseth","year":"2008","unstructured":"Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K, Nurmikko T, Zakrzewska JM. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008;71(15):1183\u201390.","journal-title":"Neurology."},{"issue":"1","key":"293_CR10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1526-4610.1969.hed0901054.x","volume":"9","author":"CF Nicol","year":"1969","unstructured":"Nicol CF. A four year double-blind study of tegretol in facial pain. Headache. 1969;9(1):54\u20137.","journal-title":"Headache."},{"issue":"2","key":"293_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archneur.1968.00480020015001","volume":"19","author":"JM Killian","year":"1968","unstructured":"Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia: use of side effects. Arch Neurol. 1968;19(2):129\u201336.","journal-title":"Arch Neurol."},{"issue":"2","key":"293_CR12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archneur.1966.00470140019003","volume":"15","author":"BW Rockliff","year":"1966","unstructured":"Rockliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol. 1966;15(2):129\u201336.","journal-title":"Arch Neurol."},{"issue":"3","key":"293_CR13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp.29.3.265","volume":"29","author":"FG Campbell","year":"1966","unstructured":"Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1966;29(3):265\u20137.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"6","key":"293_CR14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcma.2011.04.002","volume":"74","author":"S Shaikh","year":"2011","unstructured":"Shaikh S, Yaacob HB, Abd Rahman RB. Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine. J Chin Med Assoc. 2011;74(6):243\u20139.","journal-title":"J Chin Med Assoc."},{"issue":"2","key":"293_CR15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0304-3959(97)00104-8","volume":"73","author":"JM Zakrzewska","year":"1997","unstructured":"Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73(2):223\u201330.","journal-title":"Pain."},{"issue":"3","key":"293_CR16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1468-2982.1986.0603181.x","volume":"6","author":"ST Vilming","year":"1986","unstructured":"Vilming ST, Lyberg T, Lataste X. Tizanidine in the management of trigeminal neuralgia. Cephalalgia. 1986;6(3):181\u20132.","journal-title":"Cephalalgia."},{"issue":"3","key":"293_CR17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0304-3959(93)90222-B","volume":"53","author":"GH Fromm","year":"1993","unstructured":"Fromm GH, Aumentado D, Terrence CF. A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia. Pain. 1993;53(3):265\u201371.","journal-title":"Pain."},{"issue":"3","key":"293_CR18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ana.410150306","volume":"15","author":"GH Fromm","year":"1984","unstructured":"Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 1984;15(3):240\u20134.","journal-title":"Ann Neurol."},{"issue":"1","key":"293_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3959(87)91058-X","volume":"28","author":"P Lindstr\u00f6m","year":"1987","unstructured":"Lindstr\u00f6m P, Lindblom U. The analgesic effect of tocainide in trigeminal neuralgia. Pain. 1987;28(1):45\u201350.","journal-title":"Pain"},{"issue":"9","key":"293_CR20","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/archneur.1989.00520450030015","volume":"46","author":"F Lechin","year":"1989","unstructured":"Lechin F, van der Dijs B, Lechin ME, Amat J, Lechin AE, Cabrera A, et al. Pimozide therapy for trigeminal neuralgia. Arch Neurol. 1989;46(9):960\u20133.","journal-title":"Arch Neurol"},{"issue":"6","key":"293_CR21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3171\/jns.1994.80.6.0993","volume":"80","author":"D Kondziolka","year":"1994","unstructured":"Kondziolka D, Lemley T, Kestle JR, Lunsford LD, Fromm GH, Jannetta PJ. The effect of single-application topical ophthalmic anesthesia in patients with trigeminal neuralgia: a randomized double-blind placebo-controlled trial. J Neurosurg. 1994;80(6):993\u20137.","journal-title":"J Neurosurg."},{"issue":"14","key":"293_CR22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1129-2377-14-92","volume":"19","author":"HS Shehata","year":"2013","unstructured":"Shehata HS, El-Tamawy MS, Shalaby NM, Ramzy G. Botulinum toxin-type\u00a0A: could it be an effective treatment option in intractable trigeminal neuralgia? J Headache Pain. 2013;19(14):92.","journal-title":"J Headache Pain."},{"key":"293_CR23","doi-asserted-by":"crossref","unstructured":"Z\u00fa\u00f1iga C, Piedimonte F, D\u00edaz S, Micheli F. Acute treatment of trigeminal neuralgia with onabotulinum toxin\u00a0A. Clin Neuropharmacol. 2013;36(5):146\u201350.","DOI":"10.1097\/WNF.0b013e31829cb60e"},{"issue":"6","key":"293_CR24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0333102412441721","volume":"32","author":"CJ Wu","year":"2012","unstructured":"Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, Wang LJ. Botulinum toxin type\u00a0A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia. 2012;32(6):443\u201350.","journal-title":"Cephalalgia."},{"issue":"4","key":"293_CR25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1526-4610.2006.00405.x","volume":"46","author":"A Kanai","year":"2006","unstructured":"Kanai A, Saito M, Hoka S. Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache. 2006;46(4):577\u201382 (discussion 583\u20134).","journal-title":"Headache"},{"issue":"5","key":"293_CR26","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/pme.12349","volume":"15","author":"Y Niki","year":"2014","unstructured":"Niki Y, Kanai A, Hoshi K, Okamoto H. Immediate analgesic effect of 8\u00a0% lidocaine applied to the oral mucosa in patients with trigeminal neuralgia. Pain Med. 2014;15(5):826\u201331.","journal-title":"Pain Med."},{"issue":"4","key":"293_CR27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/bja\/ael180","volume":"97","author":"A Kanai","year":"2006","unstructured":"Kanai A, Suzuki A, Kobayashi M, Hoka S. Intranasal lidocaine 8\u00a0% spray for second-division trigeminal neuralgia. Br J Anaesth. 2006;97(4):559\u201363.","journal-title":"Br J Anaesth."},{"issue":"1","key":"293_CR28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1067\/moe.2001.111189","volume":"91","author":"L Reisner","year":"2001","unstructured":"Reisner L, Pettengill CA. The use of anticonvulsants in orofacial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(1):2\u20137.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod."},{"issue":"15","key":"293_CR29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1129-2377-15-34","volume":"9","author":"G Stefano Di","year":"2014","unstructured":"Di Stefano G, La Cesa S, Truini A, Cruccu G. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain. 2014;9(15):34.","journal-title":"J Headache Pain."},{"issue":"3S","key":"293_CR30","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1525-5050(02)00017-3","volume":"3","author":"A Beydoun","year":"2002","unstructured":"Beydoun A. Clinical use of tricyclic anticonvulsants in painful neuropathies and bipolar disorders. Epilepsy Behav. 2002;3(3S):S18\u201322.","journal-title":"Epilepsy Behav."},{"issue":"2","key":"293_CR31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1525-5050(03)00037-4","volume":"4","author":"E Kutluay","year":"2003","unstructured":"Kutluay E, McCague K, D\u2019Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav. 2003;4(2):175\u201380.","journal-title":"Epilepsy Behav."},{"issue":"1","key":"293_CR32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002508-200201000-00004","volume":"18","author":"SH Sindrup","year":"2002","unstructured":"Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain. 2002;18(1):22\u20137.","journal-title":"Clin J Pain."},{"key":"293_CR33","unstructured":"National Institute for Health and Care Excellence [NICE]. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. NICE clinical guideline 137. NICE. 2012. https:\/\/www.nice.org.uk\/guidance\/cg137\/resources\/guidance-the-epilepsies-the-diagnosis-and-management-of-the-epilepsies-in-adults-and-children-in-primary-and-secondary-care-pdf . Accessed 8 Aug\u00a02015."},{"issue":"3","key":"293_CR34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003088-199631030-00004","volume":"31","author":"E Spina","year":"1996","unstructured":"Spina E, Pisani F, Perucca E. Clinically significant pharmacokinetic drug interactions with carbamazepine: an update. Clin Pharmacokinet. 1996;31(3):198\u2013214.","journal-title":"Clin Pharmacokinet."},{"issue":"10","key":"293_CR35","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jocn.2010.12.054","volume":"18","author":"C Locharernkul","year":"2011","unstructured":"Locharernkul C, Shotelersuk V, Hirankarn N. Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions. J Clin Neurosci. 2011;18(10):1289\u201394.","journal-title":"J Clin Neurosci."},{"issue":"(Suppl\u00a03)","key":"293_CR36","first-page":"02.083","volume":"58","author":"A Beydoun","year":"2002","unstructured":"Beydoun A, Schmidt D, D\u2019Souza J. Oxcarbazepine versus carbamazepine in trigeminal neuralgia: a meta-analysis of three double blind comparative trails. Neurology. 2002;58((Suppl\u00a03)):02.083.","journal-title":"Neurology"},{"issue":"6","key":"293_CR37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00002512-199812060-00006","volume":"12","author":"RM Seymour","year":"1998","unstructured":"Seymour RM, Routledge PA. Important drug\u2013drug interactions in the elderly. Drugs Aging. 1998;12(6):485\u201394.","journal-title":"Drugs Aging."},{"issue":"4","key":"293_CR38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00002512-200825040-00007","volume":"25","author":"LR Tulner","year":"2008","unstructured":"Tulner LR, Frankfort SV, Gijsen GJ, van Campen JP, Koks CH, Beijnen JH. Drug\u2013drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging. 2008;25(4):343\u201355.","journal-title":"Drugs Aging."},{"issue":"2","key":"293_CR39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.amjopharm.2009.04.006","volume":"7","author":"LR Tulner","year":"2009","unstructured":"Tulner LR, Kuper IM, Frankfort SV, van Campen JP, Koks CH, Brandjes DP, Beijnen JH. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug\u2013drug interactions. Am J Geriatr Pharmacother. 2009;7(2):93\u2013104.","journal-title":"Am J Geriatr Pharmacother."},{"issue":"1\u20132","key":"293_CR40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2013.12.013","volume":"338","author":"MJ Chen","year":"2014","unstructured":"Chen MJ, Zhang WJ, Guo ZL, Zhang WH, Chai Y, Li YW. Withdrawal reaction of carbamazepine after neurovascular decompression for trigeminal neuralgia: a preliminary study. J Neurol Sci. 2014;338(1\u20132):43\u20135.","journal-title":"J Neurol Sci."},{"issue":"2","key":"293_CR41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40263-012-0023-0","volume":"27","author":"G Cruccu","year":"2013","unstructured":"Cruccu G, Truini A. Refractory trigeminal neuralgia: non-surgical treatment options. CNS Drugs. 2013;27(2):91\u20136.","journal-title":"CNS Drugs"},{"key":"293_CR42","first-page":"CD006044","volume":"12","author":"PJ Wiffen","year":"2013","unstructured":"Wiffen PJ, Derry S, Moore RA. Lamotrigine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2013;12:CD006044. doi: 10.1002\/14651858.CD006044.pub4 .","journal-title":"Cochrane Database Syst Rev"},{"key":"293_CR43","first-page":"CD007312","volume":"9","author":"JM Zakrzewska","year":"2011","unstructured":"Zakrzewska JM, Akram H. Neurosurgical interventions for the treatment of classical trigeminal neuralgia. Cochrane Database Syst Rev. 2011;9:CD007312. doi: 10.1002\/14651858.CD007312.pub2 .","journal-title":"Cochrane Database Syst Rev"},{"key":"293_CR44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/WCO.0b013e328352c465","volume":"25","author":"JM Zakrzewska","year":"2012","unstructured":"Zakrzewska JM, Coakham HB. Microvascular decompression for trigeminal neuralgia: update. Curr Opin Neurol. 2012;25:296\u2013301.","journal-title":"Curr Opin Neurol"},{"key":"293_CR45","first-page":"CD004029","volume":"12","author":"J Zhang","year":"2013","unstructured":"Zhang J, Yang M, Zhou M, He L, Chen N, Zakrzewska JM. Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst Rev. 2013;12:CD004029. doi: 10.1002\/14651858.CD004029.pub4 .","journal-title":"Cochrane Database Syst Rev"},{"key":"293_CR46","first-page":"CD010567","volume":"11","author":"PJ Wiffen","year":"2013","unstructured":"Wiffen PJ, Derry S, Moore RA, Aldington D, Cole P, Rice AS, Lunn MP, Hamunen K, Haanpaa M, Kalso EA. Antiepileptic drugs for neuropathic pain and fibromyalgia\u2014an overview of Cochrane reviews. Cochrane Database Syst Rev. 2013;11:CD010567. doi: 10.1002\/14651858.CD010567.pub2 .","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-015-0293-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-015-0293-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-015-0293-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T18:12:28Z","timestamp":1551204748000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-015-0293-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["293"],"URL":"https:\/\/doi.org\/10.1007\/s40266-015-0293-6","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}